Dysregulation of its components, such as PTEN, PIK3CA, and AKT (PKB), are common in solid tumours but despite evidence for FOXO3a down-regulation in breast cancer, the AMPK-FOXO3a pathway is still inducible. This evidence concerns the gene PTEN and breast cancer.